Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven C Katz

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 31, 2006
In vivo overexpression of Flt3 ligand expands and activates murine spleen natural killer dendritic cellsUmer I Chaudhry, Steven C Katz, T Peter Kingham, et al.
Oncogene|August 31, 2018
STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cellsPrajna Guha, Jillian Gardell, Josephine Darpolor, et al.
Current Medical Research and Opinion|February 28, 2024
Real-world evidence of Pressure-Enabled Drug Delivery for trans-arterial chemoembolization and radioembolization among patients with hepatocellular carcinoma and liver metastasesKeziah Cook, Deepshekhar Gupta, Yunjuan Liu, et al.
Cell Death Discovery|September 5, 2021
Proteomic signatures of myeloid derived suppressor cells from liver and lung metastases reveal functional divergence and potential therapeutic targetsNicholas A DaSilva, Benjamin J Barlock, Prajna Guha, et al.
Cancer Immunology Research|June 5, 2014
Tumor MHC class I expression improves the prognostic value of T-cell density in resected colorectal liver metastasesSimon Turcotte, Steven C Katz, Jinru Shia, et al.
Cancer Gene Therapy|June 4, 2019
HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA<sup>+</sup> liver metastasesSteven C Katz, John Hardaway, Ethan Prince, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Biliary obstruction selectively expands and activates liver myeloid dendritic cellsJoshua I Bleier, Steven C Katz, Umer I Chaudhry, et al.
Journal of Leukocyte Biology|July 26, 2013
Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophilsLauren A Licata, Cang T Nguyen, Rachel A Burga, et al.
Annals of Surgical Oncology|July 2, 2009
T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastasesSteven C Katz, Venu Pillarisetty, Zubin M Bamboat, et al.
The Journal of Biological Chemistry|February 27, 2007
A host lipase detoxifies bacterial lipopolysaccharides in the liver and spleenBaomei Shao, Mingfang Lu, Steven C Katz, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 31, 2006
In vivo overexpression of Flt3 ligand expands and activates murine spleen natural killer dendritic cellsUmer I Chaudhry, Steven C Katz, T Peter Kingham, et al.
Oncogene|August 31, 2018
STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cellsPrajna Guha, Jillian Gardell, Josephine Darpolor, et al.
Current Medical Research and Opinion|February 28, 2024
Real-world evidence of Pressure-Enabled Drug Delivery for trans-arterial chemoembolization and radioembolization among patients with hepatocellular carcinoma and liver metastasesKeziah Cook, Deepshekhar Gupta, Yunjuan Liu, et al.
Cell Death Discovery|September 5, 2021
Proteomic signatures of myeloid derived suppressor cells from liver and lung metastases reveal functional divergence and potential therapeutic targetsNicholas A DaSilva, Benjamin J Barlock, Prajna Guha, et al.
Cancer Immunology Research|June 5, 2014
Tumor MHC class I expression improves the prognostic value of T-cell density in resected colorectal liver metastasesSimon Turcotte, Steven C Katz, Jinru Shia, et al.
Cancer Gene Therapy|June 4, 2019
HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA<sup>+</sup> liver metastasesSteven C Katz, John Hardaway, Ethan Prince, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Biliary obstruction selectively expands and activates liver myeloid dendritic cellsJoshua I Bleier, Steven C Katz, Umer I Chaudhry, et al.
Journal of Leukocyte Biology|July 26, 2013
Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophilsLauren A Licata, Cang T Nguyen, Rachel A Burga, et al.
Annals of Surgical Oncology|July 2, 2009
T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastasesSteven C Katz, Venu Pillarisetty, Zubin M Bamboat, et al.
The Journal of Biological Chemistry|February 27, 2007
A host lipase detoxifies bacterial lipopolysaccharides in the liver and spleenBaomei Shao, Mingfang Lu, Steven C Katz, et al.
Pageof 8